- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05140577
Reliability and Validity of the Evaluation of Hip Abductors Strength (RAVEHABDS) (RAVEHABDS)
Reliability and Validity of the Measurement Procedure for the Evaluation of Hip Abductors Strength in Unipodal Standing Position
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Within this Master thesis project, we will investigate intra- and inter-tester reliability, as well as construct validity of a measurement procedure to assess hip abductor strength in a closed-chain position. Additionally, we aim to investigate some aspects of feasibility using a questionnaire about the measurement procedure and by evaluating if the test can be completing in a suitable timeframe for practical use.
To investigate intra- and inter-tester reliability, as well as construct validity, we will analyze and compare the maximal voluntary isometric strength (MVIS) and the rate of force generated (RFG) of the three groups of healthy participant (group 1: 18-30 years old; group 2: 31-65 years old; group 3: 65+ years old).
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
Bern
-
Ittigen, Bern, Switzerland, 3063
- Sport Medical Center Ittigen
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Persons over 18 years old, good understanding of French, German, English or Italian, with the capacity of discernment regarding their own participation in the study
Exclusion Criteria:
- Persons with cognitive impairment or who are unable to take their own decisions about participation in the study, or who have undergone surgery on the lower limb or lumbopelvic area during the last 6 months that could contradict or influence the strength tests, will be excluded from the study
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
18-30 years old
Subjects in this group is aged between 18 ans 30 years old
|
The subject is asked to perform a maximum voluntary isometric force work against a wall during 5 seconds
|
|
31-65 years old
Subjects in this group is aged between 31 ans 65 years old
|
The subject is asked to perform a maximum voluntary isometric force work against a wall during 5 seconds
|
|
65+ years old
Subjects in this group is aged over 65 years old
|
The subject is asked to perform a maximum voluntary isometric force work against a wall during 5 seconds
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intra-tester Correlation
Time Frame: 1 March, 2022
|
Strength of correlation the measured values
|
1 March, 2022
|
|
Inter-tester correlation
Time Frame: 1 March, 2022
|
Strength of correlation the measured values
|
1 March, 2022
|
|
Construct validity
Time Frame: 1 March, 2022
|
Difference between groups by comparing values
|
1 March, 2022
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of the measurement procedure
Time Frame: 1 March, 2022
|
Through the administration of a feasibility questionnaire we investigate the time to perform the test, the understanding of the instructions, the fatigue, the possible pain, or the fear of falling during the test
|
1 March, 2022
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2021-01829
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy People
-
Universidade Federal do vale do São FranciscoConselho Nacional de Desenvolvimento Científico e TecnológicoRecruiting
-
Qilu Pharmaceutical Co., Ltd.Unknown
-
Tel-Aviv Sourasky Medical CenterUnknown
-
Tel-Aviv Sourasky Medical CenterUnknown
-
MindMics IncRecruiting
-
Hangzhou Nuochi Life Science Co., Ltd.Completed
-
Qilu Pharmaceutical Co., Ltd.Completed
-
Tel-Aviv Sourasky Medical CenterNutrigal LTDUnknown
-
Tel-Aviv Sourasky Medical CenterNutrigal LTDUnknown
-
Ankara Yildirim Beyazıt UniversityCompleted
Clinical Trials on Maximal voluntary isometric strengthening
-
Camila Velo EtcheverryNot yet recruiting
-
University of BelgradeUniversity of Primorska, Faculty of Health SciencesCompletedQuadriceps Muscle FunctionSerbia
-
University of LiegeRecruitingAnkle Sprain | Chronic Ankle Instability, CAIBelgium
-
Loma Linda UniversityCompletedFocus: Effect of Muscle Activation on CMAP in Normal HumansUnited States
-
Taichung Veterans General HospitalRecruitingStroke | Arthroplasty, Replacement, Knee | Resistance Training | Arthroplasty, Replacement, HipTaiwan
-
University of PittsburghCompletedMuscle Fiber Atrophy, Type IIUnited States
-
Riphah International UniversityRecruitingAthletic Performance and Injury RiskPakistan
-
Grant SandersUniversity of KentuckyCompletedSubluxation of Joint of Lumbar SpineUnited States
-
Riphah International UniversityCompletedDevelopmental DelayPakistan
-
Health Education Research Foundation (HERF)Completed